Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH3 | Q9ULD8 | 12/20 | 0.57 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.41 |
| ▸ | IDH2 | P48735 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | CDK1 | P06493 | 2/20 | 0.39 |
| ▸ | CDK4 | P11802 | 2/20 | 0.39 |
| ▸ | CDK2 | P24941 | 2/20 | 0.39 |
| ▸ | KDR | P35968 | 2/20 | 0.39 |
| ▸ | CDK7 | P50613 | 2/20 | 0.39 |
| ▸ | CDK9 | P50750 | 2/20 | 0.39 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.39 |
| ▸ | CCND1 | P24385 | 1/20 | 0.39 |
| ▸ | CCNH | P51946 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | GPR39 | O43194 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.38 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30448563 | 1.00 | KCNH3 (0.57) | KCNH3NPSR1ENPP2IDH2CA2 | |
| SCHEMBL793178 | 1.00 | KCNH3 (0.57) | KCNH3NPSR1ENPP2IDH2CA2 | |
| SCHEMBL893019 | 0.99 | KCNH3 (0.56) | KCNH3NPSR1ENPP2IDH2CA2 | |
| SCHEMBL893017 | 0.90 | KCNH3 (0.55) | KCNH3NPSR1CA2CDK1CDK4 | |
| SCHEMBL29885454 | 0.90 | KCNH3 (0.55) | KCNH3NPSR1CA2CDK1CDK4 | |
| SCHEMBL893015 | 0.90 | KCNH3 (0.55) | KCNH3NPSR1CA2CDK1CDK4 | |
| SCHEMBL11618474 | 0.88 | KCNH3 (0.46) | KCNH3ENPP2CA2CDK2 | |
| SCHEMBL16374878 | 0.88 | KCNH3 (0.46) | KCNH3ENPP2CA2CDK2 | |
| SCHEMBL168451 | 0.87 | ENPP2 (0.49) | ENPP2IDH2CA2CDK2MEN1 | |
| SCHEMBL11625123 | 0.87 | ENPP2 (0.49) | ENPP2IDH2CA2CDK2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0578872-B1 | Detergent compositions | PROCTER & GAMBLE (US) | 1998-10-14 | — | — | EP | claimed |
| US-11624059-B2 | Detergent compositions comprising GH9 endoglucanase variants II | HENKEL AG & CO. KGAA (DE) | 2023-04-11 | — | — | US | disclosed |
| US-20200239815-A1 | DETERGENT COMPOSITIONS COMPRISING GH9 ENDOGLUCANASE VARIANTS II | HENKEL AG & CO. KGAA (DE) | 2020-07-30 | — | — | US | disclosed |
| US-7172891-B2 | Polypeptides having xyloglucanase activity and nucleic acids encoding same | NOVOZYMES, INC. (US) | 2007-02-06 | — | — | US | disclosed |
| US-20060110797-A1 | Polypeptides having xyloglucanase activity and nucleic acids encoding same | NOVOZYMES, INC. (US) | 2006-05-25 | — | — | US | disclosed |
| US-7033811-B2 | Polypeptides having xyloglucanase activity and nucleic acids encoding same | NOVOZYMES, INC. (US) | 2006-04-25 | — | — | US | disclosed |
| EP-1499629-A4 | POLYPEPTIDES HAVING XYLOGLUCANASE ACTIVITY AND NUCLEIC ACIDS ENCODING SAME | NOVOZYMES INC (US) | 2006-03-29 | — | — | EP | disclosed |
| EP-1499629-A2 | POLYPEPTIDES HAVING XYLOGLUCANASE ACTIVITY AND NUCLEIC ACIDS ENCODING SAME | Novozymes Biotech, Inc. (US) | 2005-01-26 | — | — | EP | disclosed |
| US-20040067569-A1 | Polypeptides having xyloglucanase activity and nucleic acids encoding same | NOVOZYMES BIOTECH, INC. | 2004-04-08 | — | — | US | disclosed |
| WO-2003089598-A2 | POLYPEPTIDES HAVING XYLOGLUCANASE ACTIVITY AND NUCLEIC ACIDS ENCODING SAME | NOVOZYMES BIOTECH, INC (US) | 2003-10-30 | — | — | WO | disclosed |
| EP-0051986-B1 | DETERGENT COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1985-05-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040067569-A1 | Polypeptides having xyloglucanase activity and nucleic acids encoding same | ENGASE, RNGTT, RNASE1 | KCNH3 4401/4885NPSR1 2963/4885ENPP2 861/4885 |
| US-20060110797-A1 | Polypeptides having xyloglucanase activity and nucleic acids encoding same | ENGASE, RNGTT, RNASE1 | KCNH3 4401/4885NPSR1 2963/4885ENPP2 861/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.